نتائج البحث 461-470 من 15546 لعملية البحث عن macular degeneration
... disease June 04, 2024, 02:58 p.m. CDT; Mayo neuroscientists discover unknown brain area involved in movement May 24, 2023, 03:00 p.m. CDT. المنتجات والخدمات.
Centers for Disease Control and Prevention. https://www.cdc.gov/cmv/congenital-infection.html. Accessed Jan. 22, 2020. Demmler-Harrison GJ. Congenital ...
... disease stage. Multiscale EEG Dynamics. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose if this study to combine state of the art cerebral signal ...
The purpose of this study is to describe the outcome and complications in surgical management of Preiser',s disease in the past 30 years in the Mayo Clinic.
This drug combination is still experimental and is not approved by the FDA. Discontinuation of pirtobrutinib and venetoclax based on minimal residual disease ( ...
The purpose of this study is to evaluate sporadic (s-) and familial (f-) frontotemporal lobar degeneration (FTLD) patients and asymptomatic family members of f- ...
The purpose of this study is to identify a biomarker (or biomarkers) that is present when disease is present (i.e., at diagnosis or recurrence) and not ...
Journal of Central Nervous System Disease. 2022; doi:10.1177/11795735221109745. Quality check. The Joint Commission. https://www.qualitycheck.org/search ...
The purpose of this study is to identify a biomarker (or biomarkers) that is present when disease is present (i.e., at diagnosis or recurrence) and not present ...
As new technologies develop, these cells may be able to be grown into new cells to replace those damaged by disease or injury. A Safety to Evaluate the ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.